Trial Profile
Examination of the symptom by a pharmacist performing continuously inhalational instruction for the asthmatic patients who newly introduced Symbicort Tubuhaler.
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 02 Nov 2017
Price :
$35
*
At a glance
- Drugs Budesonide/formoterol (Primary)
- Indications Asthma
- Focus Therapeutic Use
- 02 Nov 2017 New trial record